Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT03886246 |
| Consolidated Lead Sponsor | LEO Pharma |
| Therapeutic Condition Cohort | Immunology, Rheumatology, and Dermatology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | ACTIVE NOT RECRUITING |
| Registered Enrollment | 131 participants (ACTUAL) |
| Registered Start Date | 2019-05-29 |
| WhyStopped Classification | Not Stopped |
Named U.S. Hospital Clinical Research Sites
| Hospital Research Site | Location | Site Profile |
|---|---|---|
| Mount Sinai Hospital and Icahn School of Medicine | New York, NY | Open Hospital Dossier -> |
| Cliniques Universitaires Saint-Luc | Brussels, Belgium | Open Hospital Dossier -> |
| The Second Affiliated Hospital Zhejiang University School of Medicine | Hangzhou, China | Open Hospital Dossier -> |
| Huashan Hospital, Fudan University | Shanghai, China | Open Hospital Dossier -> |
Search related sites and sponsors in the Interactive Directory, explore Immunology, Rheumatology, and Dermatology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.